---
title: "CHENGYIPHARMA: Sodium Cytidine Diphosphate Injection has passed the consistency evaluation of generic drugs"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/230950160.md"
description: "CHENGYIPHARMA announced that its sodium cytidine injection has passed the consistency evaluation of generic drugs by the National Medical Products Administration, mainly used for consciousness disorders after acute traumatic brain injury and brain surgery. The company's cumulative R&D investment in the consistency evaluation of this drug is approximately RMB 4.2843 million (unaudited)"
datetime: "2025-03-07T08:06:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/230950160.md)
  - [en](https://longbridge.com/en/news/230950160.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/230950160.md)
---

# CHENGYIPHARMA: Sodium Cytidine Diphosphate Injection has passed the consistency evaluation of generic drugs

According to the Zhitong Finance APP, CHENGYIPHARMA (603811.SH) announced that it has recently received the "Drug Supplement Application Approval Notice" issued by the National Medical Products Administration. The sodium cytidine injection produced by the company has passed the consistency evaluation of generic drug quality and efficacy.

Sodium cytidine injection is mainly used for consciousness disorders after acute cranial trauma and brain surgery. As of the announcement date, the company has invested approximately RMB 4.2843 million (unaudited) in the consistency evaluation of this drug

### Related Stocks

- [603811.CN](https://longbridge.com/en/quote/603811.CN.md)

## Related News & Research

- [U.S. job openings rise to 7.618 million in Apr](https://longbridge.com/en/news/288439111.md)
- [Lupin share price in focus after USFDA nod for generic Sutab tablets](https://longbridge.com/en/news/288197098.md)
- [Lifechanging Dehp® High Treatment Presented at the 37th Annual Boston Trauma Conference](https://longbridge.com/en/news/287961725.md)
- [12:00 ETBLUE CROSS BLUE SHIELD OF MASSACHUSETTS RANKED #1 IN MEMBER SATISFACTION AND TRUST BY JD POWER](https://longbridge.com/en/news/288094589.md)
- [Hummingbird Diagnostics to Present New Findings Linking Ribosome Quality Control Pathway to Liquid Biopsy Biomarkers for Lung Cancer at EACR](https://longbridge.com/en/news/288389421.md)